AUTHORS
Julia Rice, APRN-CNP, Shelly Brown, DNP, MS, APRN-CNS, OCN, AOCNS2, Bradley Blaser, MD3, Cassidy Devins, BSN, RN, OCN4, Shinal Patel, APRN-CNP5, Danielle Dunnington, RN6, Gregory Behbehani, MD, PhD7
AFFILIATIONS
1 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
2 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
3 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
4 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
5 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
6 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
7 Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
ABSTRACT
Background:
As treatments for acute leukemias advance, there has been a shift in the burden of care from the inpatient to the outpatient setting. While shorter hospitalizations may help to improve resource utilization and patient experience, it also reduces opportunities for reinforced education. Patient education is often delivered using non-standardized methods, and understanding is not formally assessed. Important knowledge deficits may go unrecognized despite completion of routine education, particularly as patients transition to outpatient-based care. A standardized educational assessment was developed to identify knowledge gaps and evaluate patient retention of key concepts.
Aims:
To assess patient understanding and retention of key disease and treatment-related concepts using a standardized educational assessment and determine whether targeted re-education improves patient knowledge before outpatient follow-up.
Methods:
This single-center retrospective quality improvement pilot included adult patients newly diagnosed with acute leukemia receiving intensive or non-intensive chemotherapy between March 22, 2026, and July 15, 2026. A standardized educational assessment tool was developed, consisting of 11 educational domains related to their disease. All domains were initially scored during the inpatient hospitalization. Each domain was scored from 0–2 (0 = no understanding, 1 = partial understanding, 2 = complete understanding). Advanced practice providers re-educated patients on any domain that scored less than 2. Patients were re-scored following hospital discharge.
Results:
25 patients were evaluated, and at baseline no patient had complete understanding of all 11 educational domains. The primary analysis was restricted to 11 patients assessed at both baseline and follow-up. In a cumulative-link mixed-effects model including educational domain as a fixed effect and patient as a random intercept, follow-up scores were significantly higher than baseline scores (proportional OR 3.39, 95% CI 1.94–5.92; p<0.001).
Analysis included 113 complete patient-domain pairs (understanding scores for a given patient in each domain at baseline and follow-up) were evaluated. 84 patient-domain pairs (74%) showed unsatisfactory patient understanding at baseline (score < 2), triggering re-education. After re-education, 40 patient-domain pairs improved from baseline (47.6%) and 26 reached a complete level of understanding (31%). At baseline, the educational domain with the lowest understanding score was medication exposure precautions (0.36 +/- 0.5). The highest understanding score at baseline was the role of BMT (1.6 +/-0.70). At reassessment, the educational domain with the lowest understanding score was procedure timing (0.91 +/- 0.83), and the highest understanding remained the role of BMT (1.7 +/- 0.48). The educational domains with the largest improvement in understanding scores were medication exposure precautions (+0.73, 95% CI 0.20-1.3) and oral chemotherapy administration (+0.63, 95% CI 0.19 - 1.1). No domain-specific changes were significant after multiple comparison adjustments.
An exploratory analysis included chemotherapy regimen intensity as a variable. Educational scores improved from baseline to follow-up in both the low-intensity group (e.g. azacitidine/venetoclax; proportional OR 6.45, 95% CI 2.55–16.32; p<0.001) and the high-intensity group (e.g. cytarabine + daunorubicin; proportional OR 2.39, 95% CI 1.21–4.71; p=0.012). The magnitude of improvement was estimated to be 2.69 times greater in the low-intensity group than in the high-intensity group, although the timepoint-by-intensity interaction was not statistically significant (ratio of proportional odds ratios 2.69, 95% CI 0.88–8.33; p=0.084).
Conclusion:
Implementation of a standardized educational assessment with targeted reinforcement identified knowledge gaps that were not consistently recognized through routine education practices. These findings suggest that education without standardized assessment may leave important deficits in patient understanding undetected, particularly as acute leukemia care increasingly shifts to the outpatient setting. Future work will expand this quality improvement initiative into a randomized study evaluating whether structured knowledge assessment and targeted re-education improve patient retention, clinical outcomes, and patient preparedness for outpatient leukemia care.
DISCLOSURES
Julia Rice, APRN-CNP: No relevant conflicts of interest to declare.